MedDay Pharmaceuticals Overview

  • Founded
  • 2011
Founded
  • Status
  • Out of Business
  • Employees
  • 82
Employees
  • Latest Deal Type
  • Out of Business

MedDay Pharmaceuticals General Information

Description

Developer of novel therapeutics intended to focus on the treatment of nervous system disorders. The company's therapeutics offers neuroprotective and neuro repair treatment by investigating brain metabolism to address neurodegenerative diseases, enabling patients to get a recovery from nervous system disorders.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • 24-26 Rue de la Pépinière
  • 75008 Paris
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MedDay Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 25-Mar-2021 000.00 Completed Out of Business
2. Early Stage VC (Series B) 08-Apr-2016 000.00 000.00 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 09-Apr-2013 $10.3M $10.3M 000.00 Completed Startup
To view MedDay Pharmaceuticals’s complete valuation and funding history, request access »

MedDay Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 6,666,000 $1.35 $1.35 1x $1.35 41.73%
To view MedDay Pharmaceuticals’s complete cap table history, request access »

MedDay Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of novel therapeutics intended to focus on the treatment of nervous system disorders. The company's therapeuti
Biotechnology
Paris, France
82 As of 2020
000.00
00000000 00 000.00

00000000

olore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqu
0000 000000000
Cambridge, MA
0 As of 0000
0000
0000000000 0000

00000000

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur si
0000 000000000
Carmel, IN
0 As of 0000
00.000
000000 0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MedDay Pharmaceuticals Competitors (61)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aquinnah Venture Capital-Backed Cambridge, MA 0 0000 0000000000 0000
0000000000 0000000 Venture Capital-Backed Carmel, IN 0 00.000 000000 0
00000 000000000000 Formerly VC-backed Rockville, MD 00 000.00 000000000 - 000.00
0000000 Venture Capital-Backed Groningen, Netherlands 0 00000 0000000000 0 00000
0000000 0000000000 Venture Capital-Backed South San Francisco, CA 00 000.00 00000000000 000.00
You’re viewing 5 of 61 competitors. Get the full list »

MedDay Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MedDay Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 (000000 06-Mar-2017 000000000000000000 Biotechnology 00é0é000 00000 00.0
To view MedDay Pharmaceuticals’s complete acquisitions history, request access »